Company / CapEx per Share
ResMed CapEx per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.61
FY2025
5-year range
$0.61 / $0.93
FY2021-FY2025
Trend
-9.5%
vs FY2024
Sector context
#80 of 142
Health Care
What the data says
At $0.61, ResMed's capex per share ranks #80 of 142 in the Health Care sector. CapEx per Share has declined for 3 consecutive years, from $0.93 in FY2022 to $0.61 in FY2025.
Based on SEC 10-K filings.
0.61 in FY2025 with a 5-year CAGR of -1.6%.
Declined from $0.82 to $0.61 over the past 2 years.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- -12.9%
- 5-Year CAGR
- -1.6%
- 10-Year CAGR
- -
Sector benchmark
#80 of 142 in Health CareTop 56% of 142This company $0.61 Sector average $1.70
▼
-64.0% below sector average
Key checks
Key Insights
- ResMed's capex per share has declined for 3 consecutive years.
- In FY2025, capex per share decreased 9.5% year-over-year.
- Ranks #80 out of 142 companies in the Health Care sector.
- Peak capex per share was recorded in FY2022.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Altman Z-Score 3.25 (safe zone, above 2.9 threshold)
- Strong profit margin: 27.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.61 | -9.5% |
| FY2024 | $0.68 | -17.3% |
| FY2023 | $0.82 | -11.7% |
| FY2022 | $0.93 | +30.6% |
| FY2021 | $0.71 | +6.8% |
| FY2020 | $0.66 | +37.8% |
| FY2019 | $0.48 | +9.4% |
| FY2018 | $0.44 | -0.5% |
| FY2017 | $0.44 | +6.2% |
| FY2016 | $0.42 | -6.5% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026